A16V (p.Ala16Val) variant of NCF2 (Neutrophil cytosol factor 2)
A16V (p.Ala16Val) in NCF2 (Neutrophil cytosol factor 2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes experimental measurements and structural context.
A16V (p.Ala16Val) variant details
- p.Ala16Val
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available
- NCF2 SH3 domain domainome 1.0: score -0.461